Pyrogallol

Pyrogallol

SCHEMBL5366226

O=S(=O)(O)c1ccccc1.Oc1cccc(O)c1O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

BTKCACNA1CCACNA1DCACNA1FCACNA1SCACNA2D1CACNA2D2DRD2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQHRH1HTR2AP2RY12

The experimentally established mechanism targets of Pyrogallol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
POLB P06746 2/20 0.53
CYP2D6 P10635 1/20 0.53
ALDH1A1 P00352 5/20 0.52
HSD17B10 Q99714 4/20 0.52
CA1 P00915 3/20 0.52
CA2 P00918 3/20 0.52
MMP2 P08253 3/20 0.52
LMNA P02545 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
CA6 P23280 2/20 0.52
MMP9 P14780 2/20 0.52
HPGD P15428 2/20 0.52
MMP8 P22894 2/20 0.52
ADAMTS4 O75173 1/20 0.52
EGFR P00533 1/20 0.52
FYN P06241 1/20 0.52
ALOX15 P16050 1/20 0.52
CDK2 P24941 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrogallol SCHEMBL2879498 1.00 TSHR (0.70) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
Catechol SCHEMBL7650516 0.89 TSHR (0.80) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL27876060 0.87 TRPA1 (0.61) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL125188 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL3409457 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL30307036 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL30812783 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
Benzene SCHEMBL9751882 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL30671620 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1
SCHEMBL1079321 0.83 TSHR (1.00) TSHRSMN1; SMN2POLBCYP2D6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11142629-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element TOKYO OHKA KOGYO CO., LTD. (JP) 2021-10-12 US disclosed
US-10747113-B2 Method of pattern formation and method of producing polysilane resin precursor TOKYO OHKA KOGYO CO., LTD. (JP) 2020-08-18 US disclosed
US-20190300674-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT TOKYO OHKA KOGYO CO., LTD. (JP) 2019-10-03 US disclosed
US-10023540-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element TOKYO OHKA KOGYO CO., LTD. (JP) 2018-07-17 US disclosed
US-20180181002-A1 METHOD OF PATTERN FORMATION AND METHOD OF PRODUCING POLYSILANE RESIN PRECURSOR TOKYO OHKA KOGYO CO., LTD. (JP) 2018-06-28 US disclosed
US-9981914-B2 2018-05-29 US disclosed
US-20180086717-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT TOKYO OHKA KOGYO CO., LTD. (JP) 2018-03-29 US disclosed
US-7179399-B2 Material for forming protective film TOKYO OHKA KOGYO CO., LTD. (JP) 2007-02-20 US disclosed
US-6693049-B2 FILLING WITH AN OXYALKYLATED MELAMINE, BENZOGUANAMINE, ACETOGUANAMINE, GLYCOL URYL, UREA, THIOUREA, GUANIDINE, ALKYLENEUREA OR SUCCINYLAMIDE AND HEATING AT 150-250 C, WHEREBY NO BUBBLE IS GENERATED WHEN THE FINE HOLE IS FILLED. TOKYO OHKA KOGYO CO., LTD. (JP) 2004-02-17 US disclosed
US-20030032280-A1 Method for filling fine hole TOKYO OHKA KOGYO CO., LTD. (JP) 2003-02-13 US disclosed
US-20020182360-A1 Material for forming protective film TOKYO OHKA KOGYO CO., LTD. (JP) 2002-12-05 US disclosed
EP-0749044-B1 Positive-working photoresist composition TOKYO OHKA KOGYO CO LTD (JP) 2000-09-06 EP disclosed
EP-0749046-B1 Positive-working photoresist composition TOKYO OHKA KOGYO CO LTD (JP) 2000-05-10 EP disclosed
US-5948589-A HIGH SENSITIVITY AND HIGH RESOLUTION CAPABLE OF EXHIBITING HIGH STABILITY OF LATENT IMAGES; TERT-BUTYOXYCARBONYL-SUBSTITUTED POLYVINYLPHENOL AND ALKOXYALKYL-SUBSTITUTED POLYVINYLPHENOL. TOKYO OHKA KOGYO CO., LTD. (JP) 1999-09-07 US disclosed
US-5874195-A Positive-working photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1999-02-23 US disclosed
US-5856058-A HALATION INHIBITOR WHICH IS AN ESTERIFICATION PRODUCT BETWEEN A SPECIFIED PHENOLIC COMPOUND AND A NAPHTHOQUINONE-1,2-DIAZIDE SULFONIC ACID. TOKYO OHKA KOGYO CO., LTD. (JP) 1999-01-05 US disclosed
US-5770343-A Positive-working photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1998-06-23 US disclosed
EP-0749046-A1 Positive-working photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1996-12-18 EP disclosed
EP-0749044-A2 Positive-working photoresist composition TOKYO OHKA KOGYO CO., LTD. (JP) 1996-12-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10747113-B2 Method of pattern formation and method of producing polysilane resin precursor RTN4, RER1, CROCC TSHR 4531/4885SMN1; SMN2 1231/4885POLB 792/4885
US-20180181002-A1 METHOD OF PATTERN FORMATION AND METHOD OF PRODUCING POLYSILANE RESIN PRECURSOR RTN4, RER1, CROCC TSHR 4531/4885SMN1; SMN2 1231/4885POLB 792/4885
US-20180086717-A1 HYDROGEN BARRIER AGENT, HYDROGEN BARRIER FILM FORMING COMPOSITION, HYDROGEN BARRIER FILM, METHOD FOR PRODUCING HYDROGEN BARRIER FILM, AND ELECTRONIC ELEMENT SLC9A2, SLC9A1, NHERF1 TSHR 4035/4885SMN1; SMN2 4063/4885POLB 2120/4885
US-10023540-B2 Hydrogen barrier agent, hydrogen barrier film forming composition, hydrogen barrier film, method for producing hydrogen barrier film, and electronic element SLC9A2, SLC9A1, NHERF1 TSHR 4035/4885SMN1; SMN2 4063/4885POLB 2120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.